Callio Therapeutics is a series a startup. 1 investor tracked.
Callio Therapeutics is a startup based in the United States. Its most recent tracked round is Series A. Brouky records 2 investors associated with the company.
Callio Therapeutics is focused on realizing the promise of multi-payload antibody-drug conjugates (ADCs) to improve cancer therapy, developing next-generation, multi-payload ADCs that feature differentiated payload and linker technologies to enable targeted delivery of multi agents to tumor cells.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.